Oliver Cácananta | Owner & Principal Consultant

Oliver is a 28-year veteran of the biopharmaceutical industry, having worked broadly with biologics, medical devices, and small-molecule drugs. He has extensive involvement in collaboration or leadership of approved marketing and investigational regulatory filings as well as CMC and other pre- and post-approval commitment submissions, and in organizing and participating in various agency interactions. His global experience spans multiple therapeutic areas, including vaccines, biodefense medical countermeasures, diabetes, metabolic and inflammatory bowel disorders, endovascular disease, blood pathogen reduction technologies, and cell and gene therapies. He has worked with partners and agencies across the Americas, Europe, Asia-Pacific, Latin America, and the Middle East. Oliver received his B.S. in biological science at California State University, East Bay, and an M.B.A. in global management from the University of Phoenix.